A detailed history of Capital World Investors transactions in Abbott Laboratories stock. As of the latest transaction made, Capital World Investors holds 1,337,231 shares of ABT stock, worth $155 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,337,231
Holding current value
$155 Million
% of portfolio
0.02%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$100.07 - $118.13 $134 Million - $158 Million
1,337,231 New
1,337,231 $152 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $46,484 - $54,533
489 Added 0.02%
3,245,993 $356 Million
Q3 2022

Nov 14, 2022

BUY
$96.76 - $112.03 $50,992 - $59,039
527 Added 0.02%
3,245,504 $314 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $432,164 - $522,348
-4,234 Reduced 0.13%
3,244,977 $353 Million
Q1 2022

May 16, 2022

SELL
$114.02 - $139.04 $834,398 - $1.02 Million
-7,318 Reduced 0.22%
3,249,211 $385 Million
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $1.12 Million - $1.37 Million
9,701 Added 0.3%
3,256,529 $458 Million
Q3 2021

Nov 15, 2021

SELL
$116.66 - $129.06 $58.1 Million - $64.2 Million
-497,662 Reduced 13.29%
3,246,828 $384 Million
Q2 2021

Aug 16, 2021

SELL
$105.79 - $124.53 $6.78 Million - $7.98 Million
-64,107 Reduced 1.68%
3,744,490 $434 Million
Q1 2021

May 14, 2021

BUY
$108.84 - $128.23 $110 Million - $129 Million
1,008,721 Added 36.03%
3,808,597 $456 Million
Q4 2020

Feb 12, 2021

BUY
$105.0 - $114.42 $4 Million - $4.36 Million
38,101 Added 1.38%
2,799,876 $307 Million
Q3 2020

Nov 13, 2020

BUY
$91.64 - $111.29 $153,588 - $186,522
1,676 Added 0.06%
2,761,775 $301 Million
Q2 2020

Aug 14, 2020

BUY
$76.57 - $98.0 $177 Million - $226 Million
2,307,943 Added 510.43%
2,760,099 $252 Million
Q1 2020

May 15, 2020

BUY
$62.82 - $91.86 $13.8 Million - $20.1 Million
218,887 Added 93.83%
452,156 $35.7 Million
Q4 2019

Feb 18, 2020

BUY
$78.51 - $87.4 $11,305 - $12,585
144 Added 0.06%
233,269 $20.3 Million
Q3 2019

Nov 14, 2019

BUY
$81.84 - $88.74 $327 - $354
4 Added 0.0%
233,125 $19.5 Million
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $8,818 - $10,285
121 Added 0.05%
233,121 $19.6 Million
Q1 2019

May 15, 2019

BUY
$66.22 - $80.06 $15.4 Million - $18.7 Million
233,000 New
233,000 $18.6 Million
Q4 2018

Feb 14, 2019

SELL
$65.56 - $74.27 $141 Million - $160 Million
-2,151,000 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$60.81 - $73.36 $131 Million - $158 Million
2,151,000 New
2,151,000 $158 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Capital World Investors Portfolio

Follow Capital World Investors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital World Investors, based on Form 13F filings with the SEC.

News

Stay updated on Capital World Investors with notifications on news.